Back to Tango Therapeutics, Inc.

Tango Therapeutics, Inc.

All insider transactions

15 transactions

DateMoveSecurityInsiderΔ sharesPriceValueHeld afterImpact
Mar 25, 2026Sell
Common StockCrystal Adam
Executive
-12,000$20.11$241.3K112,622medium
Mar 25, 2026Other
Option exercise
Common StockCrystal Adam
Executive
+12,000$5.20$62.4K124,622low
Mar 5, 2026SellCommon StockCrystal Adam
Executive
-20,251$15.00$303.8K112,622medium
Feb 25, 2026SellCommon StockCrystal Adam
Executive
-54,345$12.77$694.2K132,873medium
Feb 3, 2026SellCommon StockCrystal Adam
Executive
-201$12.90$2.6K187,218low
Feb 3, 2026SellCommon StockCrystal Adam
Executive
-18,251$12.26$223.7K187,419medium
Feb 3, 2026SellCommon StockBeckman Daniella
Executive
-113$12.90$1.5K184,297low
Feb 3, 2026SellCommon StockBeckman Daniella
Executive
-10,204$12.26$125.1K184,410medium
Feb 3, 2026SellCommon StockWeber Barbara
Executive
-333$12.90$4.3K1,629,254low
Feb 3, 2026SellCommon StockWeber Barbara
Executive
-30,186$12.26$370.0K1,629,587medium
Feb 2, 2026Other
Grant / award
Common StockCrystal Adam
Executive
+47,460$0.00$0205,670low
Feb 2, 2026Other
Grant / award
Common StockBeckman Daniella
Executive
+44,330$0.00$0194,614low
Feb 2, 2026Other
Grant / award
Common StockWeber Barbara
Executive
+37,522$0.00$01,659,773low
Jan 8, 2026Other
Grant / award
Common StockPeters Malte
CEO
+350,000$0.00$0367,500low
Jan 2, 2026Other
Grant / award
Common StockLee Sung
Director
+10,000$0.00$010,000low
← PrevPage 1 of 1Next →